Screener
Aura Biosciences, Inc. AURA Accounts Payable
Accounts Payable at other companies
Other financials
Where this comes from
Reported directly by Aura Biosciences, Inc. in its filing.
Tagged under the XBRL concept us-gaap:AccountsPayableCurrent.
The source filing: Aura Biosciences, Inc.’s 10-Q, filed May 11, 2026.
- Filed
- May 11, 2026, 4:15 PM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001193125-26-216808
| Line item | March 31, 2026 | December 31, 2025 |
|---|---|---|
| Total Assets | $137,677 | $169,430 |
| Liabilities and Stockholders’ Equity | ||
| Current liabilities: | ||
| Accounts payable | 2,573 | 1,549 |
| Short-term operating lease liability | 3,267 | 3,243 |
| Accrued expenses and other current liabilities | 10,866 | 13,591 |
| Total current liabilities | 16,706 | 18,383 |
| Long-term operating lease liability | 13,724 | 14,134 |
Item 1. Financial Statements.
FAQ
- What is Aura Biosciences, Inc.'s accounts payable?
- Aura Biosciences, Inc. (AURA) reported accounts payable of $2.57M in Q1 2026.
- How has Aura Biosciences, Inc.'s accounts payable changed year-over-year?
- Aura Biosciences, Inc.'s accounts payable increased by 28.3% year-over-year, from $2.01M to $2.57M.
- What is the long-term trend for Aura Biosciences, Inc.'s accounts payable?
- Over 4 years (2021 to 2025), Aura Biosciences, Inc.'s accounts payable has grown at a 4.0% compound annual growth rate (CAGR), from $5.75M to $6.73M.
- What does accounts payable mean?
- Amounts owed to suppliers and vendors for goods and services received but not yet paid. A primary source of short-term trade financing.
Ask your AI about Aura Biosciences, Inc.'s accounts payable.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude